SMTL ID : 5o1b.2 (1 other biounit)

p53 cancer mutant Y220C in complex with compound MB84

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.43 Å

Oligo State

monomer

Ligands

1 x ZN: ZINC ION(Non-covalent)

ZN.1: 4 residues within 4Å: Chain A: C.83, H.86, C.145, C.149 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:C.83, A:H.86, A:C.145, A:C.149

1 x 9H2: 6-(hydroxymethyl)-2,4-bis(iodanyl)-3-pyrrol-1-yl-phenol(Non-covalent)

9H2.2: 9 residues within 4Å: Chain A: L.52, V.54, T.57, C.127, E.128, P.129, P.130, D.135, T.137 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:L.52, A:T.57 Halogen bonds: A:L.52

2 x GOL: GLYCEROL(Non-functional Binders)

GOL.3: 4 residues within 4Å: Chain A: Y.146, S.148, C.182, A.183 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:S.148, A:A.183 Water bridges: A:S.148, A:C.184, A:D.188 GOL.4: 5 residues within 4Å: Chain A: R.81, Q.99, D.114, F.119, H.121 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:R.81, A:R.81, A:F.119 Water bridges: A:Q.99

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Baud, M.G.J. et al., Aminobenzothiazole derivatives stabilize the thermolabile p53 cancer mutant Y220C and show anticancer activity in p53-Y220C cell lines. Eur J Med Chem (2018)

Release Date

2018-05-09

Peptides

Cellular tumor antigen p53: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Cellular tumor antigen p53

Related Entries With Identical Sequence